Anti-viral compounds
Compounds effective in inhibiting replication of Hepatitis C virus (“HCV”) are described. This invention also relates to processes of making such compounds, compositions comprising such compounds, and methods of using such compounds to treat HCV infection.
AbbVie Inc.
A Y A A A A A C A A A C C A A A C A A C C A C A A A C
A61K Y02P A61K A61K A61K A61P A61P C07D A61K A61K A61K C07D C07D A61K A61K A61K C07D A61K A61P C07D C07D A61K C07F A61K A61K A61K C07D
inventional additional inventional inventional inventional inventional inventional inventional inventional inventional inventional inventional inventional inventional inventional inventional inventional inventional inventional inventional inventional inventional inventional inventional inventional inventional inventional
Charles W. Tammie K. Charles A. Kathy Dachun David A. Lissa T. Clarence J. Ryan G. Sachin V. Todd W. John K. Pamela L. Daniel D. Seble H. David A. Michael D. John T. Jean-Christophe C. Mary E. Warren M. Christopher E. Douglas K. Rolf William A. Kevin R. Allan C. Wenke Yi Mark A.
Hutchins Jinkerson Flentge Sarris Liu Betebenner Nelson Maring Keddy Patel Rockway Pratt Donner Caspi Wagaw DeGoey Tufano Randolph Califano Bellizzi Kati Motter Hutchinson Wagner Carroll Woller Krueger Li Gao Matulenko